NASDAQ
Design Therapeutics, Inc. (DSGN) has a fcf yield of -10.14% as of Friday, May 29, 2026. This represents a 36.96% increase compared to its 12-month average of -16.09%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.